Fundraising Fox
Kenjockety Biotechnology
Los Altos Hills, US · Founded 2017 · California LLC
Find your way into Kenjockety Biotechnology
Sign up to see every warm intro you have to Kenjockety Biotechnology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kenjockety Biotechnology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kenjockety is a biotechnology company developing antibody-based therapeutics to treat cancer. The company focuses on antibody drug conjugates and bispecific antibodies targeting cancer, serving patients, families, and healthcare providers.
Founders & leadership
Kenjockety Biotechnology was founded in 2017 by Rob.
R
RobCo-founder and President and CEO
PD
Paul DeStefanoExecutive
WR
William Robert ArathoonExecutive
PN
Philippa NormanCo-founder and CFO
Board
DR
Daniel ReinerBoard director
Reported raises · per SEC filings
Form D private placements$4M disclosed across 1 round · 2017
▶$4MraisedMay 2017 · 5 investors · BiotechnologyRule 506(b)
▶$4MraisedMay 2017 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul DeStefanoExecutive Officer
- Daniel ReinerDirector
- Philippa NormanExecutive Officer, Director
- William Robert ArathoonExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Apr 2017
- Incorporated
- Limited Liability Company, California, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Kenjockety Biotechnology do?
- Kenjockety is a biotechnology company developing antibody-based therapeutics to treat cancer. The company focuses on antibody drug conjugates and bispecific antibodies targeting cancer, serving patients, families, and healthcare providers.
- Who founded Kenjockety Biotechnology?
- Kenjockety Biotechnology was founded by Rob in 2017.
- How much funding has Kenjockety Biotechnology raised?
- Kenjockety Biotechnology has disclosed $4M raised across 1 round.
- Where is Kenjockety Biotechnology headquartered?
- Kenjockety Biotechnology is headquartered in Los Altos Hills, US.